We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.02 | 6.74157303371 | 15.13 | 16.055 | 14.6 | 58954 | 15.20716766 | CS |
4 | 0.78 | 5.07482108003 | 15.37 | 16.055 | 13.51 | 72334 | 14.73978827 | CS |
12 | 0.58 | 3.72511239563 | 15.57 | 17.41 | 12.25 | 68972 | 15.06762034 | CS |
26 | 2.6 | 19.1881918819 | 13.55 | 17.79 | 10.8 | 90572 | 14.60101208 | CS |
52 | -22.22 | -57.9098253844 | 38.37 | 39.79 | 10.8 | 372245 | 31.48759462 | CS |
156 | -27.03 | -62.5984251969 | 43.18 | 44.3168 | 7.67 | 425005 | 25.04879552 | CS |
260 | -3.55 | -18.0203045685 | 19.7 | 50.97 | 7.67 | 341012 | 25.85839449 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions